Rodrigo Hamede Selected Research

7- O- (2,6- dideoxy- 2- fluorotalopyranosyl)daunomycinone

3/2022	Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD).
1/2022	Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early Diagnosis of a Transmissible Cancer.
1/2022	Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
12/2021	Disruption of Metapopulation Structure Reduces Tasmanian Devil Facial Tumour Disease Spread at the Expense of Abundance and Genetic Diversity.
9/2021	Spatial variation in gene expression of Tasmanian devil facial tumors despite minimal host transcriptomic response to infection.
1/2021	Contemporary and historical selection in Tasmanian devils (Sarcophilus harrisii) support novel, polygenic response to transmissible cancer.
12/2020	A transmissible cancer shifts from emergence to endemism in Tasmanian devils.
6/2020	Changes in spatial organization following an acute epizootic: Tasmanian devils and their transmissible cancer.
1/2020	Disease swamps molecular signatures of genetic-environmental associations to abiotic factors in Tasmanian devil (Sarcophilus harrisii) populations.
1/2020	Telomere Length is a Susceptibility Marker for Tasmanian Devil Facial Tumor Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodrigo Hamede Research Topics

Disease

26	Neoplasms (Cancer) 03/2022 - 01/2012
2	Infections 09/2021 - 01/2020
1	Latent Infection 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Persistent Infection 01/2020
1	Cachexia 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Chronic Disease (Chronic Diseases) 09/2016
1	Anemia 09/2016
1	Acute-Phase Reaction 09/2016
1	Inflammation (Inflammations) 09/2016
1	Tetraploidy 02/2014
1	Confusion (Bewilderment) 03/2013

Drug/Important Bio-Agent (IBA)

22	7- O- (2,6- dideoxy- 2- fluorotalopyranosyl)daunomycinoneIBA 03/2022 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2016
1	Antimicrobial PeptidesIBA 01/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2020
1	ElementsIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2018
1	Peptides (Polypeptides)IBA 10/2016

Therapy/Procedure

1	Precision Medicine 11/2018
1	Immunotherapy 10/2018